2Svendsen KB, Andersen S, Arnason S, et al. Breakthrough pain in malignant and non-malignant diseases: a review of prevalence, characteristics and mechanisms. Eur J Pain, 2005, 9(2) :195-206.
3刘景全,龙鲸.癌痛患者心理状况的研究.中华临床医学研究杂志,2004,10(98):2516.
4Nguyen AT, Marquez P, Hamid A, et al. The role of mu opi- old receptors in psychomotor stimulation and conditioned place preference induced by morphine-6-glucuronide. Eur J Phar- macol, 2012, 682(1-3):86-91.
5Radbruch L, Eisner F. Clinical experience with transdermal fentanyl for the treatment of cancer pain in Germany. Keio J Med, 2004, 53(1):23-29.
6Koyyalagunta D, Bruera E, Solanki DR, et al. A systematic review of randomized trials on the effectiveness of opioids for cancer pain. Pain Physician, 2012, 15(3 Suppl):ES 39-ES58.
